Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome.
暂无分享,去创建一个
Jeffrey E. Lee | Douglas B. Evans | J. Vauthey | C. Charnsangavej | R. Wolff | P. Pisters | R. Lenzi | J. Abbruzzese | N. Janjan | K. Cleary | Christopher N. Crane | C. Crane
[1] D. Kerr,et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial , 2001, The Lancet.
[2] C. Charnsangavej,et al. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] D. Iannitti,et al. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. , 2001, International journal of radiation oncology, biology, physics.
[4] G. Aletti,et al. Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study. , 2001, Gynecologic oncology.
[5] G. Weinstein,et al. Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] P. Albert,et al. Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Ciezki,et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] H. Silberman,et al. Preoperative Paclitaxel and Radiotherapy for Locally Advanced Breast Cancer: Surgical Aspects , 2000, Annals of Surgical Oncology.
[9] H J Wanebo,et al. Paclitaxel and concurrent radiation for gastric cancer. , 2000, International journal of radiation oncology, biology, physics.
[10] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[11] J. Jeekel,et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. , 1999, Annals of surgery.
[12] Jeffrey E. Lee,et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] C. Charnsangavej,et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric–portal vein confluence for adenocarcinoma of the pancreatic head , 1998, The British journal of surgery.
[14] S. Hahn,et al. Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R H Hruban,et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. , 1997, Annals of surgery.
[16] H. Choy,et al. Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Jeffrey E. Lee,et al. The Need for Standardized Pathologic Staging of Pancreaticoduodenectomy Specimens , 1996, Pancreas.
[18] D. Klimstra,et al. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. , 1996, Annals of surgery.
[19] D B Evans,et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. , 1996, Annals of surgery.
[20] M. Barton. Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula. , 1995, International journal of radiation oncology, biology, physics.
[21] Jeffrey W. Clark,et al. Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Mitchell,et al. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. , 1994, Journal of the National Cancer Institute.
[23] F. Ames,et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.
[24] P. Schiff,et al. Promotion of microtubule assembly in vitro by taxol , 1979, Nature.
[25] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[26] Earl G. Adams,et al. Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines , 2004, Cancer Chemotherapy and Pharmacology.
[27] R. Wolff,et al. Multimodality management of localized pancreatic cancer. , 2001, Cancer Journal.
[28] Jeffrey E. Lee,et al. Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration , 2001, Annals of Surgical Oncology.
[29] S. Lipsitz,et al. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Jeffrey E. Lee,et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head* , 1996 .
[31] B. Eisenberg,et al. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. , 1995, American journal of surgery.
[32] E. Hall,et al. Taxol: a novel radiation sensitizer. , 1992, International journal of radiation oncology, biology, physics.
[33] J. Cox. Time, dose, and fractionation in radiation therapy: an historical perspective. , 1988, Frontiers of radiation therapy and oncology.